Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Can B (CANB) Competitors

Can B logo

CANB vs. MEDS, BIMI, CERO, XWEL, PBM, NKGN, TTNP, SXTP, NRBO, and MOVE

Should you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), CERo Therapeutics (CERO), XWELL (XWEL), Psyence Biomedical (PBM), NKGen Biotech (NKGN), Titan Pharmaceuticals (TTNP), 60 Degrees Pharmaceuticals (SXTP), NeuroBo Pharmaceuticals (NRBO), and Movano (MOVE). These companies are all part of the "medical" sector.

Can B vs. Its Competitors

TRxADE HEALTH (NASDAQ:MEDS) and Can B (NASDAQ:CANB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, risk and valuation.

Can B has lower revenue, but higher earnings than TRxADE HEALTH.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TRxADE HEALTH$7.45M0.18-$17.84MN/AN/A
Can B$2.16M0.89-$9.74MN/AN/A

5.7% of TRxADE HEALTH shares are owned by institutional investors. Comparatively, 6.1% of Can B shares are owned by institutional investors. 48.4% of TRxADE HEALTH shares are owned by insiders. Comparatively, 11.4% of Can B shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.

Company Net Margins Return on Equity Return on Assets
TRxADE HEALTH-149.81% -196.79% -112.21%
Can B -1,238.33%N/A -218.65%

In the previous week, TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the media.

Company Overall Sentiment
TRxADE HEALTH Neutral
Can B Neutral

TRxADE HEALTH has a beta of 2.32, suggesting that its share price is 132% more volatile than the S&P 500. Comparatively, Can B has a beta of 1.46, suggesting that its share price is 46% more volatile than the S&P 500.

Summary

TRxADE HEALTH beats Can B on 6 of the 10 factors compared between the two stocks.

Get Can B News Delivered to You Automatically

Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CANB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CANB vs. The Competition

MetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$1.92M$2.43M$5.73B$10.31B
Dividend YieldN/AN/A5.90%4.63%
P/E RatioN/AN/A75.8626.51
Price / Sales0.890.18528.72123.58
Price / CashN/AN/A37.1760.46
Price / Book-0.082.1012.796.29
Net Income-$9.74M-$17.84M$3.28B$270.51M

Can B Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CANB
Can B
N/A$0.02
+27.8%
N/A+74.3%$1.92M$2.16M0.0016Gap Up
MEDS
TRxADE HEALTH
N/A$0.89
+0.3%
N/A-87.2%$1.25M$7.45M0.0050
BIMI
BIMI
N/A$0.00
flat
N/AN/A$1K$12.63M0.00520News Coverage
CERO
CERo Therapeutics
3.4169 of 5 stars
$5.50
+10.2%
$45.00
+718.2%
-96.6%$6.01MN/A0.008
XWEL
XWELL
0.7545 of 5 stars
$1.05
+1.0%
N/A-34.5%$5.99M$33.90M-0.26360
PBM
Psyence Biomedical
0.6773 of 5 stars
$3.24
+1.6%
N/A-95.0%$5.96MN/A0.00N/APositive News
Gap Up
NKGN
NKGen Biotech
0.1334 of 5 stars
$0.13
-7.0%
N/A-82.2%$5.96MN/A-0.03N/AGap Down
TTNP
Titan Pharmaceuticals
0.139 of 5 stars
$4.27
-4.0%
N/A-24.2%$5.92MN/A-1.4510Positive News
SXTP
60 Degrees Pharmaceuticals
1.9959 of 5 stars
$1.42
-0.7%
$3.00
+111.3%
-79.3%$5.87M$641.41K-0.033News Coverage
Positive News
NRBO
NeuroBo Pharmaceuticals
N/A$0.68
+0.1%
N/A-56.4%$5.85MN/A0.0010
MOVE
Movano
0.6379 of 5 stars
$0.77
+10.3%
N/A-86.3%$5.82M$1.01M-0.1930Trending News

Related Companies and Tools


This page (NASDAQ:CANB) was last updated on 9/17/2025 by MarketBeat.com Staff
From Our Partners